- Home
- PDSB vs TURN Comparison
PDSB vs TURN Comparison
Compare PDSB & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDSB
- TURN
- Stock Information
- Founded
- PDSB 2005
- TURN 1981
- Country
- PDSB United States
- TURN United States
- Employees
- PDSB N/A
- TURN N/A
- Industry
- PDSB Biotechnology: Pharmaceutical Preparations
- TURN Finance/Investors Services
- Sector
- PDSB Health Care
- TURN Finance
- Exchange
- PDSB Nasdaq
- TURN Nasdaq
- Market Cap
- PDSB 43.1M
- TURN 35.3M
- IPO Year
- PDSB N/A
- TURN N/A
- Fundamental
- Price
- PDSB $1.25
- TURN $4.00
- Analyst Decision
- PDSB Strong Buy
- TURN
- Analyst Count
- PDSB 3
- TURN 0
- Target Price
- PDSB $10.00
- TURN N/A
- AVG Volume (30 Days)
- PDSB 275.1K
- TURN 41.6K
- Earning Date
- PDSB 05-14-2025
- TURN 05-12-2025
- Dividend Yield
- PDSB N/A
- TURN N/A
- EPS Growth
- PDSB N/A
- TURN N/A
- EPS
- PDSB N/A
- TURN N/A
- Revenue
- PDSB N/A
- TURN $194,813.00
- Revenue This Year
- PDSB N/A
- TURN N/A
- Revenue Next Year
- PDSB N/A
- TURN N/A
- P/E Ratio
- PDSB N/A
- TURN N/A
- Revenue Growth
- PDSB N/A
- TURN 254.25
- 52 Week Low
- PDSB $0.85
- TURN $3.12
- 52 Week High
- PDSB $4.42
- TURN $4.20
- Technical
- Relative Strength Index (RSI)
- PDSB 55.58
- TURN 60.85
- Support Level
- PDSB $1.00
- TURN $3.59
- Resistance Level
- PDSB $1.17
- TURN $4.04
- Average True Range (ATR)
- PDSB 0.11
- TURN 0.31
- MACD
- PDSB 0.04
- TURN 0.04
- Stochastic Oscillator
- PDSB 81.61
- TURN 91.78
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.